NCT06133816Completed
Lung Cancer Screening Eligibility Assessment
Using a Simplified Tool to Predict Lung Cancer Screening (LCS) Eligibility: Experiment to Test Effects of Messaging on Response Rates
Source: ClinicalTrials.gov · Last updated 31 May 2025
Brief summary (registry, in English)
The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 6125 (actual)
- First submitted
- 18 Oct 2023
- Start date
- 31 Jul 2023
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Lung cancer
- NCT number
- NCT06133816
What you commit to
- Study type: Interventional
- Participants enrolled: 6125
- From 31 Jul 2023 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- have a documented history of lung cancer;
- have a documented history of completing LCS at Penn Medicine;
Other
- are listed as not wanting to be contacted or solicited for research; or
- do not otherwise meet inclusion criteria.
Who the study is looking for
- meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and
- have completed at least one primary care visit at Penn Medicine in 2020-2025
Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.